Stay updated on AZD8701 & Durvalumab in Advanced Solid Tumours Clinical Trial
Sign up to get notified when there's something new on the AZD8701 & Durvalumab in Advanced Solid Tumours Clinical Trial page.

Latest updates to the AZD8701 & Durvalumab in Advanced Solid Tumours Clinical Trial page
- Check5 days agoChange DetectedFooter now shows Revision: v3.4.3, replacing Revision: v3.4.2.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedAdded site revision banner "Revision: v3.4.2" and removed the previous "Revision: v3.4.1" banner (along with the funding-status notice). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check41 days agoChange DetectedA site-wide notice about a lapse in government funding and NIH Clinical Center operations was added, and the page version updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check48 days agoChange DetectedAdded a glossary toggle and small UI changes, including capitalization tweaks and a new revision tag (Revision: v3.4.0). No changes to study content, eligibility criteria, or key results were observed.SummaryDifference0.2%

- Check62 days agoChange DetectedRevision: v3.3.4 replaces v3.3.3 on the page, which appears to be a minor site update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check84 days agoChange DetectedAdded a consolidated Locations section listing trial sites in Maryland, Missouri, North Carolina, Tennessee, Texas, Wisconsin, and Ontario, and updated the page revision to v3.3.3. The previous per-location subsections and the HHS Vulnerability Disclosure section were removed.SummaryDifference0.7%

Stay in the know with updates to AZD8701 & Durvalumab in Advanced Solid Tumours Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AZD8701 & Durvalumab in Advanced Solid Tumours Clinical Trial page.